Cargando…
Immunotherapy “Shock” a case series of PD-L1 100% and pembrolizumab first-line treatment
In this decade a “bloom” of novel therapies has been observed for non-small cell lung cancer. We have new tools for the diagnosis of lung cancer and also we can re-biospy easier than before in different lesions and obtain tissue samples in order to investigate whether a patient can receive new targe...
Autores principales: | Zarogoulidis, Paul, Athanasiou, Evaggelia, Tsiouda, Theodora, Hatzibougias, Dimitrios, Huang, Haidong, Bai, Chong, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Barbetakis, Nikolaos, Paliouras, Dimitrios, Rapti, Aggeliki, Drougas, Dimitrios, Hohenforst-Schmidt, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576975/ https://www.ncbi.nlm.nih.gov/pubmed/28879076 http://dx.doi.org/10.1016/j.rmcr.2017.08.017 |
Ejemplares similares
-
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Endobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case series
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
“Liquid elbows” due to afatinib administration
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking
por: Zarogoulidis, Paul, et al.
Publicado: (2017)